Plasma Cell Granuloma

A Plasma Cell Granuloma is a type of inflammation in the body. It's a slow-growing lump that forms when the body's immune system, specifically plasma cells, reacts to something, like an infection or injury. Think of it like a small, localized area where the body is trying to fight off an invader, but it's not a typical infection.

Condition

What people with Plasma Cell Granuloma report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Plasma Cell Granuloma?

NameHow it went

About Plasma Cell Granuloma

What It Is

A plasma cell granuloma is a rare growth made of spindle-shaped connective tissue cells mixed with large numbers of inflammatory cells, especially plasma cells (the immune cells that make antibodies). Because it looks like inflammation under the microscope but forms a solid mass, it was long called an inflammatory pseudotumor. It most often appears in the lung, but it can also arise in the abdomen, bladder, sinuses, mouth, brain and other organs. The name is now largely historical. Most lesions once called plasma cell granuloma are today classified as inflammatory myofibroblastic tumor (IMT), a true tumor that is usually not cancer and rarely spreads, but can grow into nearby tissue and come back after treatment. Some other plasma cell rich masses are purely reactive inflammation, and some turn out to be IgG4-related disease, an immune condition treated differently. Sorting out which of these a person has is the main task of diagnosis, because it shapes treatment and follow-up.

Causes & Risk Factors

In many cases no cause is found. About half of inflammatory myofibroblastic tumors carry a rearrangement of a gene called ALK (anaplastic lymphoma kinase), which switches on growth signals inside the tumor cells. This change happens in the tumor itself; it is not inherited, and IMT is not known to run in families. ALK changes are more common in children and young adults, and less common in people over 40. Purely reactive inflammatory pseudotumors can follow an infection, an immune reaction or an injury, including earlier surgery. IMT can occur at any age but is found most often in children and young adults.

How It's Diagnosed

Many people come to attention because of symptoms from the mass itself: cough, chest pain or shortness of breath with a lung lesion, abdominal pain or blockage in the abdomen, blood in the urine with a bladder lesion, or headaches with a brain lesion. Others feel well and the mass is found on a scan done for another reason. About 20 to 30 percent of people with IMT have whole-body inflammation, with fever, tiredness, weight loss and blood tests showing anemia (low red blood cells) or raised inflammation markers. CT, MRI or ultrasound shows where the mass is and how large it is, but imaging cannot reliably tell it apart from cancer or infection. Diagnosis rests on a tissue sample, from a needle biopsy or from the removed mass. A pathologist examines the cells and usually tests for the ALK protein or gene change, and sometimes for other gene fusions. Other stains help rule out look-alikes such as plasma cell cancers and IgG4-related disease.

Treatment Options

Surgery to remove the whole mass is the main treatment and offers the best chance of cure. When the mass is removed completely, with a margin of normal tissue, it seldom returns; when some is left behind, regrowth is much more likely. How feasible complete removal is depends on where the mass sits and what it is touching. If it comes back, a second operation is often considered. When surgery is not possible or the tumor returns, the gene findings guide what comes next. For ALK-positive IMT, crizotinib (Xalkori), a targeted oral cancer medicine that blocks the ALK signal, is approved in the US for adults and children 1 year and older whose tumor cannot be removed, has come back or has not responded to other treatment. Other targeted medicines may be used if a different gene fusion is found or the tumor stops responding. Anti-inflammatory treatment with corticosteroids or nonsteroidal anti-inflammatory drugs has shrunk some lesions, particularly very inflamed ones, and radiation or chemotherapy is used in selected cases. Evidence for these comes from case reports and small series, so their benefit for any one person is uncertain. Small reactive lesions, such as those on the gums, are usually simply cut out.

What to Expect

The outlook is generally good. Most people whose mass is completely removed do very well over the long term, and spread to distant organs is rare. Children tend to do well even when the tumor cannot be fully removed. Outcomes are less predictable when a mass is in a hard-to-reach place, such as the brain or around major blood vessels, where complete surgery may not be possible and recurrence is more common. Because the tumor can come back, sometimes years later, follow-up usually includes regular check-ups and repeat scans for a long period. If fever, tiredness or abnormal blood tests were present before surgery, they typically settle once the mass is removed, and their return can be an early clue to recurrence. Daily life after recovery is often unaffected, though it depends on which organ was involved and how much surgery was needed.

When to Seek Help

See a clinician about a persistent cough, unexplained weight loss, ongoing fevers, a lump that does not go away, or a mass seen on a scan, so it can be properly evaluated. After treatment, contact your care team if symptoms like the original ones return, or if new pain, fever or swelling develops near where the mass was. Problems caused by a mass pressing on a vital structure, such as sudden difficulty breathing, coughing up blood, or vomiting with an inability to pass stool or gas, need same-day medical care.

Questions to Ask Your Doctor

  1. 1.Is this an inflammatory myofibroblastic tumor, a reactive inflammatory lesion or something else, and how sure is the diagnosis?
  2. 2.Was my tissue tested for ALK or other gene changes, and how do the results affect my options?
  3. 3.Can the whole mass be removed safely, and what happens if some has to be left behind?
  4. 4.How often will I need scans or check-ups, and for how many years?
  5. 5.Would it help to have my case reviewed at a center that treats rare soft tissue tumors?

Last reviewed • Oct 2026

Educational content, not medical advice.